Teacher Retirement System of Texas Decreases Holdings in Corteva, Inc. $CTVA

Key Points

• Teacher Retirement System of Texas reduced its stake in Corteva by 32.7% in Q4, selling 187,884 shares and now holds 387,392 shares worth $25.97 million (about 0.06% of the company).
• Several analysts raised price targets while JPMorgan cut its rating to neutral; Corteva's consensus analyst sentiment is Moderate Buy with a consensus price target of $84.90.
• Corteva set FY2026 EPS guidance of 3.450–3.700 (street average ~3.62), has a market cap near $53.5 billion, and pays a quarterly dividend of $0.18 (≈0.9% yield).

Teacher Retirement System of Texas decreased its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 32.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 387,392 shares of the company's stock after selling 187,884 shares during the period. Teacher Retirement System of Texas owned 0.06% of Corteva worth $25,967,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. HB Wealth Management LLC raised its holdings in shares of Corteva by 4.7% in the fourth quarter. HB Wealth Management LLC now owns 21,865 shares of the company's stock worth $1,466,000 after buying an additional 976 shares during the last quarter. Grant Street Asset Management Inc. raised its holdings in shares of Corteva by 14.8% in the fourth quarter. Grant Street Asset Management Inc. now owns 3,877 shares of the company's stock worth $260,000 after buying an additional 500 shares during the last quarter. Kingswood Wealth Advisors LLC raised its holdings in shares of Corteva by 11.8% in the fourth quarter. Kingswood Wealth Advisors LLC now owns 9,819 shares of the company's stock worth $658,000 after buying an additional 1,035 shares during the last quarter. Bedel Financial Consulting Inc. raised its holdings in shares of Corteva by 5.0% in the fourth quarter. Bedel Financial Consulting Inc. now owns 3,875 shares of the company's stock worth $260,000 after buying an additional 183 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in shares of Corteva by 8.7% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 586,914 shares of the company's stock worth $39,355,000 after buying an additional 47,015 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on CTVA. JPMorgan Chase & Co. cut shares of Corteva from an "overweight" rating to a "neutral" rating and raised their price target for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Corteva in a report on Wednesday. Royal Bank Of Canada raised their price target on shares of Corteva from $80.00 to $89.00 and gave the stock an "outperform" rating in a report on Thursday, February 5th. Jefferies Financial Group raised their price target on shares of Corteva from $85.00 to $95.00 and gave the stock a "buy" rating in a report on Monday, March 2nd. Finally, Mizuho raised their price target on shares of Corteva from $82.00 to $94.00 and gave the stock an "outperform" rating in a report on Wednesday, April 15th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $84.90.

Corteva Stock Up 0.4%

CTVA stock opened at $79.66 on Friday. The firm has a market cap of $53.48 billion, a PE ratio of 50.41, a P/E/G ratio of 2.72 and a beta of 0.68. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The firm's fifty day moving average is $80.00 and its 200 day moving average is $71.49. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm's revenue was down 1.7% on a year-over-year basis. During the same quarter last year, the business earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts forecast that Corteva, Inc. will post 3.62 EPS for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva's dividend payout ratio (DPR) is currently 45.57%.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of the firm's stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.15% of the company's stock.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.